findmyKOL

Randall Trudell, MD

Basic profile

University of Tennessee Medical Center

ORCIDNone on fileNPI
RegionKnoxville, TN · SoutheastSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Randall Trudell is a Neurology physician affiliated with University of Tennessee Medical Center. OpenAlex indexes 5 publications with 654 citations (h-index 3).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
5publications

Distinct works indexed by OpenAlex.

654citations

Total citations across indexed works.

3h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
40companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2200 Sutherland Ave.
Knoxville, TN 37919

Telephone

865-521-6174

Registry record last updated 6 Jul 2009.

View the NPPES registry record

Industry payments

40 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    61.5%
    Gabapentinoids11%
    Gabapentin81%Pregabalin19%
    Part D90 patients
    Benzodiazepine8.2%
    Clonazepam41%Alprazolam32%Lorazepam16%Diazepam11%
    Part D<11 patients

    + 29 more classes in this area

  • Cancer & immunology

    17.5%
    Sphingosine 1-phosphate Receptor Modulator6.3%
    Mayzent31%Gilenya30%Fingolimod28%Zeposia11%
    Part D<11 patients
    Pyrimidine Synthesis Inhibitor5%
    Teriflunomide86%Aubagio14%
    Part D<11 patients

    + 6 more classes in this area

  • Musculoskeletal

    15.7%
    gamma-Aminobutyric Acid-ergic Agonist8.6%
    Baclofen100%
    Part D82 patients
    Central alpha-2 Adrenergic Agonist3.5%
    Tizanidine Hcl100%
    Part D34 patients

    + 3 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”